Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of cetuximab + cisplatin + topotecan in advanced or recurrent cervical epithelial cancer
2006-004328-35Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Dec 2006
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cetuximab, cisplatin and topotecan in Cervical Cancer (CC), sponsored by ARCAGY. Primary endpoint: Objective response rate. Started Dec 2006; status: completed.
02
Drugs
cetuximabcisplatintopotecan
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2006-004328-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004328-35.